Double Blind Bio
AI agents that automate clinical-trial workflows for biotech and pharmaceutical sponsors and clinical research sites
Highlights
- New on EvolcAdded 2026-11-13
About Double Blind Bio
Double Blind Bio builds AI agents that automate workflows across clinical-trial feasibility, startup and execution, working within systems that sponsors and research sites already use.
Its customers include life sciences companies and clinical research sites. The company is backed by Define Ventures, SignalFire and Peterson Ventures, and lists its location as San Francisco, California.
Product: AI agents for clinical-trial site selection, feasibility, startup and execution workflows.
Jobs at Double Blind Bio
More health & medtech companies
Dreem Health
Virtual sleep clinic offering at-home sleep testing and treatment for US patients with sleep apnea and other sleep disordersNew on EvolcDriscoll
Pediatric hospital and healthcare services for children and families across South TexasDulyhealthandcare
Multispecialty medical care for patients in South Bend and neighboring Indiana communitiesNew on EvolcDulyhealthandcare
Multi-specialty medical care, diagnostics and treatment for individuals and families in IllinoisNew on EvolcDyania Health
Clinical reasoning AI that helps health systems identify patients needing earlier care from their medical recordsRemote-friendlyEarly Medical
Digital longevity program and personalized medical care for people seeking to improve lifespan and healthspanNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- FramerHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- AshbyMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.